A social science framework for the analysis of health technology regulation: the risks and benefits of innovative pharmaceuticals in a comparative context

By Abraham John  

Health, Risk & Society, Vol. 4, Iss. 3, 2002-11 ,pp. : 305-324

Routledge Ltd

Access to resources Recommend Favorite

Patient access to pharmaceuticals: an international comparison

By Cohen Joshua   Faden Laura   Predaris Susan   Young Brian  

The European Journal of Health Economics, Vol. 8, Iss. 3, 2007-09 ,pp. : 253-266

Springer Publishing Company

Access to resources Recommend Favorite

Risks, rights and regulation: an overview

By Turner Bryan S.  

Health, Risk & Society, Vol. 3, Iss. 1, 2001-03 ,pp. : 9-18

Routledge Ltd

Access to resources Recommend Favorite

Governing peanuts: the regulation of the social bodies of children and the risks of food allergies

By Rous T.   Hunt A.  

Social Science and Medicine, Vol. 58, Iss. 4, 2004-02 ,pp. : 825-836

Elsevier

Access to resources Recommend Favorite

Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 7, 2015-07 ,pp. : 709-715

John Wiley & Sons Inc

Access to resources Recommend Favorite